Nektar Posted Promising Alopecia Results. Here's Why It Took A 22% Beating.
Nektar Therapeutics stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients.
The post Nektar Posted Promising Alopecia Results. Here's Why It Took A 22% Beating. appeared first on Investor's Business Daily .